Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 12
Therapeutics and Clinical Risk Management
ISSN: 1178-203X
- View all (2283)
- Volume 19, 2023 (66)
- Volume 18, 2022 (104)
- Volume 17, 2021 (134)
- Volume 16, 2020 (134)
- Volume 15, 2019 (154)
- Volume 14, 2018 (271)
- Volume 13, 2017 (188)
- Volume 12, 2016 (217)
- Volume 11, 2015 (210)
- Volume 10, 2014 (113)
- Volume 9, 2013 (57)
- Volume 8, 2012 (47)
- Volume 7, 2011 (59)
- Volume 6, 2010 (66)
- Volume 5, 2009 (102)
- Volume 4, 2008 (148)
- Volume 3, 2007 (126)
- Volume 2, 2006 (47)
- Volume 1, 2005 (40)
Archive: Volume 12, 2016
Impact of preoperative chronic renal failure on liver transplantation: a population-based cohort study
Chung PC, Chen HP, Lin JR, Liu FC, Yu HP
Therapeutics and Clinical Risk Management 2016, 12:1855-1860
Published Date: 14 December 2016
Clinical features of brain metastases in breast cancer: an implication for hippocampal-sparing whole-brain radiation therapy
Wu S, Sun J, Tong Q, Li F, He Z
Therapeutics and Clinical Risk Management 2016, 12:1849-1853
Published Date: 13 December 2016
Kinetics of circulating endothelial progenitor cells in patients undergoing carotid artery surgery
Kalender G, Kornberger A, Lisy M, Beiras-Fernandez A, Stock UA
Therapeutics and Clinical Risk Management 2016, 12:1841-1847
Published Date: 14 December 2016
High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis
Ishikawa K, Nagai T, Sakamoto K, Ohara K, Eguro T, Ito H, Toyoshima Y, Kokaze A, Toyone T, Inagaki K
Therapeutics and Clinical Risk Management 2016, 12:1831-1840
Published Date: 5 December 2016
Complete blood cell count components and coronary slow-flow phenomenon
Arjmand N, Dehghani MR
Therapeutics and Clinical Risk Management 2016, 12:1827-1829
Published Date: 2 December 2016
Ceftolozane/tazobactam and ceftazidime/avibactam for the treatment of complicated intra-abdominal infections
Goodlet KJ, Nicolau DP, Nailor MD
Therapeutics and Clinical Risk Management 2016, 12:1811-1826
Published Date: 1 December 2016
Preoperative risk factors in total thyroidectomy of substernal goiter
Bove A, Di Renzo RM, D'Urbano G, Bellobono M, D'Addetta V, Lapergola A, Bongarzoni G
Therapeutics and Clinical Risk Management 2016, 12:1805-1809
Published Date: 28 November 2016
Role of anuria in the relationship between indoxyl sulfate and anemia in peritoneal dialysis patients
Huang JY, Hsu CW, Yang CW, Hung CC, Huang WH
Therapeutics and Clinical Risk Management 2016, 12:1797-1803
Published Date: 28 November 2016
Comparative efficacy of bilastine, levocetirizine and desloratadine updosing in chronic urticaria
Staevska MT
Therapeutics and Clinical Risk Management 2016, 12:1793-1796
Published Date: 25 November 2016
Health behaviors of patients diagnosed with type 2 diabetes mellitus and their influence on the patients’ satisfaction with life
Rosiek A, Kornatowski T, Frąckowiak-Maciejewska N, Rosiek-Kryszewska A, Wyżgowski P, Leksowski K
Therapeutics and Clinical Risk Management 2016, 12:1783-1792
Published Date: 25 November 2016
Balanced discussion of second-generation antihistamines' data
Boev R, Bentz JWG
Therapeutics and Clinical Risk Management 2016, 12:1777-1781
Published Date: 24 November 2016
Chronotherapy with low-dose modified-release prednisone for the management of rheumatoid arthritis: a review
Beltrametti SP, Ianniello A, Ricci C
Therapeutics and Clinical Risk Management 2016, 12:1763-1776
Published Date: 21 November 2016
Thyroid dysfunction among type 2 diabetic female Egyptian subjects
Elebrashy IN, El Meligi A, Rashed L, Salam RF, Youseef E, Fathy SA
Therapeutics and Clinical Risk Management 2016, 12:1757-1762
Published Date: 21 November 2016
Pharmaceutical interventions in the management of tuberculosis in a pneumophtisiology department, Ivory Coast
Abrogoua DP, Kamenan BAT, Ahui BJM, Doffou E
Therapeutics and Clinical Risk Management 2016, 12:1749-1756
Published Date: 22 November 2016
Intestinal permeability in a patient with liver cirrhosis
Aguirre Valadez JM, Rivera-Espinosa L, Méndez-Guerrero O, Chávez-Pacheco JL, García Juárez I, Torre A
Therapeutics and Clinical Risk Management 2016, 12:1729-1748
Published Date: 18 November 2016
Protective effect of tartary buckwheat on renal function in type 2 diabetics: a randomized controlled trial
Qiu J, Li ZG, Qin YC, Yue YF, Liu YP
Therapeutics and Clinical Risk Management 2016, 12:1721-1727
Published Date: 18 November 2016
The effect of body mass index on perioperative thermoregulation
Özer AB, Yildiz Altun A, Erhan ÖL, Çatak T, Karatepe Ü, Demirel İ, Çağlar Toprak G
Therapeutics and Clinical Risk Management 2016, 12:1717-1720
Published Date: 18 November 2016
Treatment cost of narcolepsy with cataplexy in Central Europe
Maresova P, Novotny M, Klímová B, Kuča K
Therapeutics and Clinical Risk Management 2016, 12:1709-1715
Published Date: 18 November 2016
Predictive value of serum uric acid in hospitalized adolescents and adults with acute asthma
Abdulnaby NK, Sayed AO, Shalaby NM
Therapeutics and Clinical Risk Management 2016, 12:1701-1708
Published Date: 14 November 2016
Effectiveness of etofenamate for treatment of knee osteoarthritis: a randomized controlled trial
Güner S, Gökalp MA, Gözen A, Ünsal SŞ, Güner Şİ
Therapeutics and Clinical Risk Management 2016, 12:1693-1699
Published Date: 14 November 2016
Relationships between Th1/Th2 cytokine profiles and chest radiographic manifestations in childhood Mycoplasma pneumoniae pneumonia
Zhao JL, Wang X, Wang YS
Therapeutics and Clinical Risk Management 2016, 12:1683-1692
Published Date: 11 November 2016
Comparison of the glottic view during video-intubation in super obese patients: a series of cases
Gaszyński T
Therapeutics and Clinical Risk Management 2016, 12:1677-1682
Published Date: 11 November 2016
An observational postmarketing safety registry of patients in the UK, Germany, and Switzerland, who have been prescribed Sativex® (THC:CBD, nabiximols) oromucosal spray
Etges T, Karolia K, Grint T, Taylor A, Lauder H, Daka B, Wright S
Therapeutics and Clinical Risk Management 2016, 12:1667-1675
Published Date: 11 November 2016
Inflammation-modulating cytokine profile and lipid interaction in HIV-related risk factors for cardiovascular diseases
Gori E, Mduluza T, Nyagura M, Stray-Pedersen B, Gomo ZA
Therapeutics and Clinical Risk Management 2016, 12:1659-1666
Published Date: 11 November 2016
Utilization of gastroprotective strategies for nonsteroidal anti-inflammatory drug-induced gastrointestinal events in a major teaching hospital
Lee HL, Chua SS, Mahadeva S
Therapeutics and Clinical Risk Management 2016, 12:1649-1657
Published Date: 10 November 2016
Antiallergic effect of the atomized extract of rhizome of Curcuma longa, flowers of Cordia lutea and leaves of Annona muricata
Arroyo-Acevedo J, Franco-Quino C, Ruiz-Ramírez E, Chávez-Asmat R, Anampa-Guzmán A, Raéz-González E, Cabanillas-Coral J
Therapeutics and Clinical Risk Management 2016, 12:1643-1647
Published Date: 10 November 2016
Comparative effect and safety of verapamil in keloid and hypertrophic scar treatment: a meta-analysis
Li ZN, Jin ZH
Therapeutics and Clinical Risk Management 2016, 12:1635-1641
Published Date: 9 November 2016
Management of extrapulmonary sarcoidosis: challenges and solutions
Al-Kofahi K, Korsten P, Ascoli C, Virupannavar S, Mirsaeidi M, Chang I, Qaqish N, Saketkoo LA, Baughman RP, Sweiss NJ
Therapeutics and Clinical Risk Management 2016, 12:1623-1634
Published Date: 7 November 2016
Shear wave elastography imaging for assessing the chronic pathologic changes in advanced diabetic kidney disease
Hassan K, Loberant N, Abbas N, Fadi H, Shadia H, Khazim K
Therapeutics and Clinical Risk Management 2016, 12:1615-1622
Published Date: 7 November 2016
Patent ductus arteriosus with persistent pulmonary artery hypertension after transcatheter closure
Feng JQ, Kong XQ, Sheng YH, Yang R
Therapeutics and Clinical Risk Management 2016, 12:1609-1613
Published Date: 3 November 2016
Laparoscopic total extraperitoneal repair under spinal anesthesia versus general anesthesia: a randomized prospective study
Donmez T, Erdem VM, Sunamak O, Erdem DA, Avaroglu HI
Therapeutics and Clinical Risk Management 2016, 12:1599-1608
Published Date: 27 October 2016
Costs of inguinal hernia repair associated with using different medical devices in the Czech Republic
Marešová P, Peteja M, Lerch M, Zonca P, Kuca K
Therapeutics and Clinical Risk Management 2016, 12:1593-1597
Published Date: 26 October 2016
Secukinumab for ankylosing spondylitis and psoriatic arthritis
Lubrano E, Perrotta FM
Therapeutics and Clinical Risk Management 2016, 12:1587-1592
Published Date: 21 October 2016
Therapy of psoriasis with narrowband ultraviolet-B light influences plasma concentrations of MMP-2 and TIMP-2 in patients
Głażewska EK, Niczyporuk M, Ławicki S, Szmitkowski M, Zajkowska M, Będkowska GE, Przylipiak A
Therapeutics and Clinical Risk Management 2016, 12:1579-1585
Published Date: 21 October 2016
The potential role for use of mitochondrial DNA copy number as predictive biomarker in presbycusis
Falah M, Houshmand M, Najafi M, Balali M, Mahmoudian S, Asghari A, Emamdjomeh H, Farhadi M
Therapeutics and Clinical Risk Management 2016, 12:1573-1578
Published Date: 19 October 2016
High-frequency oscillatory ventilation is an effective treatment for severe pediatric acute respiratory distress syndrome with refractory hypoxemia
Guo YX, Wang ZN, Li YT, Pan L, Yang LF, Hu Y, Sun YY, Cai LM, Chen ZG
Therapeutics and Clinical Risk Management 2016, 12:1563-1571
Published Date: 19 October 2016
The use of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmatics
Benfante A, Basile M, Battaglia S, Spatafora M, Scichilone N
Therapeutics and Clinical Risk Management 2016, 12:1553-1562
Published Date: 14 October 2016
Comparison of classical diagnostic criteria and Chinese revised diagnostic criteria for fever of unknown origin in Chinese patients
Li JJ, Huang WX, Shi ZY, Sun Q, Xin XJ, Zhao JQ, Yin Z
Therapeutics and Clinical Risk Management 2016, 12:1545-1551
Published Date: 12 October 2016
Impact of statins on risk of new onset diabetes mellitus: a population-based cohort study using the Korean National Health Insurance claims database
Lee J, Noh Y, Shin S, Lim H, Park RW, Bae SK, Oh E, Kim GJ, Kim JH, Lee S
Therapeutics and Clinical Risk Management 2016, 12:1533-1543
Published Date: 11 October 2016
Mathematical evaluation of the influence of multiple factors on implant stability quotient values in clinical practice: a retrospective study
Huang H, Wismeijer D, Shao X, Wu G
Therapeutics and Clinical Risk Management 2016, 12:1525-1532
Published Date: 11 October 2016
Inappropriateness of medication prescriptions about chronic kidney disease patients without dialysis therapy in a Chinese tertiary teaching hospital
Yang P, Chen N, Wang RR, Li L, Jiang SP
Therapeutics and Clinical Risk Management 2016, 12:1517-1524
Published Date: 12 October 2016
Association of medications for lifestyle-related diseases with reflux esophagitis
Asaoka D, Nagahara A, Hojo M, Matsumoto K, Ueyama H, Matsumoto K, Izumi K, Takeda T, Komori H, Akazawa Y, Shimada Y, Osada T, Watanabe S
Therapeutics and Clinical Risk Management 2016, 12:1507-1515
Published Date: 4 October 2016
New developments in acne treatment: role of combination adapalene–benzoylperoxide
Kim SY, Ochsendorf FR
Therapeutics and Clinical Risk Management 2016, 12:1497-1506
Published Date: 3 October 2016
Cataract induction by administration of nitroglycerin in cardiac patients through imbalance in redox status
El-Gharabawy RM, Ahmed AS, Al-Najjar AH
Therapeutics and Clinical Risk Management 2016, 12:1487-1496
Published Date: 27 September 2016
The effects of magnesium sulfate therapy after severe diffuse axonal injury
Zhao L, Wang W, Zhong J, Li YY, Cheng YZ, Su Z, Zheng W, Guan XD
Therapeutics and Clinical Risk Management 2016, 12:1481-1486
Published Date: 27 September 2016
Is there any superiority among diagnostic methods in organizing pneumonia in terms of clinical features of the patients?
Kavakli K, Ocal N, Dogan D, Cicek AF, Isik H, Gurkok S
Therapeutics and Clinical Risk Management 2016, 12:1473-1479
Published Date: 26 September 2016
Combined treatment in punctate inner choroidopathy
Terelak-Borys B, Zagajewska K, Jankowska-Lech I, Tesla P, Grabska-Liberek I
Therapeutics and Clinical Risk Management 2016, 12:1467-1471
Published Date: 23 September 2016
Efficacy and safety of daptomycin for skin and soft tissue infections: a systematic review with trial sequential analysis
Liu C, Mao Z, Yang MM, Kang HJ, Liu H, Pan L, Hu J, Luo J, Zhou FH
Therapeutics and Clinical Risk Management 2016, 12:1455-1466
Published Date: 22 September 2016
Clinical, pathological, and radiological characteristics of solitary ground-glass opacity lung nodules on high-resolution computed tomography
Qiu ZX, Cheng Y, Liu D, Wang WY, Wu X, Wu WL, Li WM
Therapeutics and Clinical Risk Management 2016, 12:1445-1453
Published Date: 20 September 2016
Long-term safety of tiotropium delivered by Respimat® SoftMist™ Inhaler: patient selection and special considerations
Tan CK, Say GQ, Geake JB
Therapeutics and Clinical Risk Management 2016, 12:1433-1444
Published Date: 21 September 2016
In vitro and in vivo postmarketing surveillance of valsartan, alone or in combination with amlodipine or hydrochlorthiazide, among Palestinian hypertensive patients
Zaid AN, Ghanem M, Shweiki D, Shtewi H, Shaheen R, Al Helaly S, Khayyat Z, Al Ramahi R, Zyoud SH
Therapeutics and Clinical Risk Management 2016, 12:1425-1432
Published Date: 19 September 2016
Association of low serum aluminum level with mortality in hemodialysis patients
Hsu CW, Weng CH, Lee CC, Lin-Tan DT, Chen KH, Yen TH, Huang WH
Therapeutics and Clinical Risk Management 2016, 12:1417-1424
Published Date: 14 September 2016
Clinical prediction rules for failed nonoperative reduction of intussusception
Khorana J, Patumanond J, Ukarapol N, Laohapensang M, Visrutaratna P, Singhavejsakul J
Therapeutics and Clinical Risk Management 2016, 12:1411-1416
Published Date: 13 September 2016
Reporting of adverse events related to dietary supplements to a public health center by medical staff: a survey of clinics and pharmacies
Ide K, Yamada H, Kawasaki Y, Noguchi M, Kitagawa M, Chiba T, Kagawa Y, Umegaki K
Therapeutics and Clinical Risk Management 2016, 12:1403-1410
Published Date: 12 September 2016
The association of serum gamma-glutamyl transpeptidase level and other laboratory parameters with blood pressure in hypertensive patients under ambulatory blood pressure monitoring
Ortakoyluoglu A, Boz B, Dizdar OS, Avcı D, Cetinkaya A, Baspınar O
Therapeutics and Clinical Risk Management 2016, 12:1395-1401
Published Date: 7 September 2016
Patients’ safety: is there a systemic release of gentamicin by gentamicin-coated tibia nails in clinical use?
Moghaddam A, Graeser V, Westhauser F, Dapunt U, Kamradt T, Woerner SM, Schmidmaier G
Therapeutics and Clinical Risk Management 2016, 12:1387-1393
Published Date: 7 September 2016
Changes in oxidative stress from tracheal aspirates sampled during chest physical therapy in hospitalized intubated infant patients with pneumonia and secretion retention
Leelarungrayub J, Borisuthibandit T, Yankai A, Boontha K
Therapeutics and Clinical Risk Management 2016, 12:1377-1386
Published Date: 6 September 2016
Retargeting the management of hypercholesterolemia – focus on evolocumab
Colletti A, Derosa G, Cicero AFG
Therapeutics and Clinical Risk Management 2016, 12:1365-1376
Published Date: 6 September 2016
Clinical analysis of contributors to the delayed gallbladder opacification following the use of water-soluble contrast medium
Ku MC, Kok VC, Lee MY, Hsu SM, Lee PY, Chang CW, Tyan YS, Juan CW
Therapeutics and Clinical Risk Management 2016, 12:1357-1364
Published Date: 6 September 2016
Anti-vascular endothelial growth factor treatment in diabetic macular edema
Kim M
Therapeutics and Clinical Risk Management 2016, 12:1355-1356
Published Date: 2 September 2016
Safety of long-term use of linezolid: results of an open-label study
Vazquez JA, Arnold AC, Swanson RN, Biswas P, Bassetti M
Therapeutics and Clinical Risk Management 2016, 12:1347-1354
Published Date: 1 September 2016
Does surgical treatment within 4 hours after trauma have an influence on neurological remission in patients with acute spinal cord injury?
Biglari B, Child C, Yildirim TM, Swing T, Reitzel T, Moghaddam A
Therapeutics and Clinical Risk Management 2016, 12:1339-1346
Published Date: 31 August 2016
Long-term outcomes and prognostic analysis of modified open-door laminoplasty with lateral mass screw fusion in treatment of cervical spondylotic myelopathy
Su N, Fei Q, Wang B, Li D, Li J, Meng H, Yang Y, Guo A
Therapeutics and Clinical Risk Management 2016, 12:1329-1337
Published Date: 31 August 2016
Rituximab use in adult primary glomerulopathy: where is the evidence?
Mallat SG, Itani HS, Abou-Mrad RM, Abou Arkoub R, Tanios BY
Therapeutics and Clinical Risk Management 2016, 12:1317-1327
Published Date: 29 August 2016
Surgical versus conservative treatment following acute rupture of the Achilles tendon: is there a pedobarographic difference?
Karaaslan F, Mermerkaya MU, Çıraklı A, Karaoğlu S, Duygulu F
Therapeutics and Clinical Risk Management 2016, 12:1311-1315
Published Date: 29 August 2016
Clinical use of blinatumomab for B-cell acute lymphoblastic leukemia in adults
Lee KJ, Chow V, Weissman A, Tulpule S, Aldoss I, Akhtari M
Therapeutics and Clinical Risk Management 2016, 12:1301-1310
Published Date: 25 August 2016
Open-label trial on efficacy of artemether/lumefantrine against the uncomplicated Plasmodium falciparum malaria in Metema district, Northwestern Ethiopia
Wudneh F, Assefa A, Nega D, Mohammed H, Solomon H, Kebede T, Woyessa A, Assefa Y, Kebede A, Kassa M
Therapeutics and Clinical Risk Management 2016, 12:1293-1300
Published Date: 24 August 2016
Predialysis hypotension is not a predictor for mortality in long-term hemodialysis patients: insight from a single-center observational study
Huang WH, Hsu CW, Hu CC, Yen TH, Weng CH
Therapeutics and Clinical Risk Management 2016, 12:1285-1292
Published Date: 24 August 2016
How does hospitalization affect continuity of drug therapy: an exploratory study
Blozik E, Signorell A, Reich O
Therapeutics and Clinical Risk Management 2016, 12:1277-1283
Published Date: 22 August 2016
Vojta method in the treatment of developmental hip dysplasia – a case report
Kiebzak W, Żurawski A, Dwornik M
Therapeutics and Clinical Risk Management 2016, 12:1271-1276
Published Date: 19 August 2016
Clinical management of a challenging malignancy, osteoblastoma-like osteosarcoma: a report of four cases and a review of the literature
Ozger H, Alpan B, Söylemez MS, Ozkan K, Salduz A, Bilgic B, Sirin BK
Therapeutics and Clinical Risk Management 2016, 12:1261-1270
Published Date: 17 August 2016
The association between methylated CDKN2A and cervical carcinogenesis, and its diagnostic value in cervical cancer: a meta-analysis
Li J, Zhou C, Zhou H, Bao T, Gao T, Jiang X, Ye M
Therapeutics and Clinical Risk Management 2016, 12:1249-1260
Published Date: 18 August 2016
Investigation of cerebral iron deposition in aged patients with ischemic cerebrovascular disease using susceptibility-weighted imaging
Liu Y, Liu J, Liu H, Liao Y, Cao L, Ye B, Wang W,
Therapeutics and Clinical Risk Management 2016, 12:1239-1247
Published Date: 16 August 2016
Prognostic indicators for failed nonsurgical reduction of intussusception
Khorana J, Singhavejsakul J, Ukarapol N, Laohapensang M, Siriwongmongkol J, Patumanond J
Therapeutics and Clinical Risk Management 2016, 12:1231-1237
Published Date: 9 August 2016
The risk factors and prevention of cardiovascular disease: the importance of electrocardiogram in the diagnosis and treatment of acute coronary syndrome
Rosiek A, Leksowski K
Therapeutics and Clinical Risk Management 2016, 12:1223-1229
Published Date: 8 August 2016
Elevated blood plasma levels of epinephrine, norepinephrine, tyrosine hydroxylase, TGFβ1, and TNFα associated with high-altitude pulmonary edema in Indian population
Pandey P, Ali Z, Mohammad G, Pasha MAQ
Therapeutics and Clinical Risk Management 2016, 12:1207-1221
Published Date: 8 August 2016
Role of isavuconazole in the treatment of invasive fungal infections
Wilson DT, Dimondi VP, Johnson SW, Jones TM, Drew RH
Therapeutics and Clinical Risk Management 2016, 12:1197-1206
Published Date: 3 August 2016
Impact of baseline systolic blood pressure on visit-to-visit blood pressure variability: the Kailuan study
Wang A, Li Z, Yang Y, Chen G, Wang C, Wu Y, Ruan C, Liu Y, Wang Y, Wu S
Therapeutics and Clinical Risk Management 2016, 12:1191-1196
Published Date: 2 August 2016
Clinical efficacy and safety of autologous stem cell transplantation for patients with ST-segment elevation myocardial infarction
Li R, Li XM, Chen JR
Therapeutics and Clinical Risk Management 2016, 12:1171-1189
Published Date: 1 August 2016
Eculizumab in the management of paroxysmal nocturnal hemoglobinuria: patient selection and special considerations
Al-Ani F, Chin-Yee I, Lazo-Langner A
Therapeutics and Clinical Risk Management 2016, 12:1161-1170
Published Date: 1 August 2016
Emerging approaches in Parkinson’s disease – adjunctive role of safinamide
Müller T
Therapeutics and Clinical Risk Management 2016, 12:1151-1160
Published Date: 2 August 2016
Repeated adjacent segment diseases and fractures in osteoporotic patients: a case report
Chen HY, Chen CL, Chen WL
Therapeutics and Clinical Risk Management 2016, 12:1145-1150
Published Date: 28 July 2016
A bypass case due to an acute inferior myocardial infarction caused by vascular occlusion of the left subclavian artery and left anterior descending artery
Altas Y, Ulug AV
Therapeutics and Clinical Risk Management 2016, 12:1139-1143
Published Date: 26 July 2016
Effect of biological factors on successful measurements with skeletal-muscle 1H-MRS
Isobe T, Okamoto Y, Hirano Y, Ando H, Takada K, Sato E, Shinoda K, Tadano K, Takei H, Kamizawa S, Mori Y, Suzuki H
Therapeutics and Clinical Risk Management 2016, 12:1133-1137
Published Date: 20 July 2016
An overview of the effect of sodium glucose cotransporter 2 inhibitor monotherapy on glycemic and other clinical laboratory parameters in type 2 diabetes patients
Wang Y, Hu X, Liu X, Wang Z
Therapeutics and Clinical Risk Management 2016, 12:1113-1131
Published Date: 15 July 2016
Comparison of continuous epidural infusion and programmed intermittent epidural bolus in labor analgesia
Lin Y, Li Q, Liu J, Yang R, Liu J
Therapeutics and Clinical Risk Management 2016, 12:1107-1112
Published Date: 14 July 2016
Efficacy and safety outcomes of ticagrelor compared with clopidogrel in Chinese elderly patients with acute coronary syndrome
Wang HD, Wang X
Therapeutics and Clinical Risk Management 2016, 12:1101-1105
Published Date: 14 July 2016
Is there a relationship between fracture healing and mean platelet volume?
Serbest S, Tiftikci U, Tosun HB, Gumustas SA, Uludag A
Therapeutics and Clinical Risk Management 2016, 12:1095-1099
Published Date: 13 July 2016
Correlation between obesity and chronic kidney disease: is obstructive sleep apnea an interfering factor?
Santos-Camilo M, Arães SP, Hirotsu C, Tufik S, Andersen ML
Therapeutics and Clinical Risk Management 2016, 12:1093-1094
Published Date: 11 July 2016
Relationship between the iceA gene of Helicobacter pylori and clinical outcomes
Huang XJ, Deng ZM, Zhang Q, Li WY, Wang BN, Li MY
Therapeutics and Clinical Risk Management 2016, 12:1085-1092
Published Date: 6 July 2016
Profile of eliglustat tartrate in the management of Gaucher disease [Corrigendum]
Sechi A, Dardis A, Bembi B
Therapeutics and Clinical Risk Management 2016, 12:1083-1084
Published Date: 7 July 2016
Role of biologics in severe eosinophilic asthma – focus on reslizumab
Pelaia G, Vatrella A, Busceti MT, Gallelli L, Preianò M, Lombardo N, Terracciano R, Maselli R
Therapeutics and Clinical Risk Management 2016, 12:1075-1082
Published Date: 1 July 2016
Papillary thyroid carcinoma risk factors in the Yunnan plateau of southwestern China
Zeng R, Shou T, Yang KX, Shen T, Zhang JP, Zuo RX, Zheng YQ, Yan XM
Therapeutics and Clinical Risk Management 2016, 12:1065-1074
Published Date: 30 June 2016
Atrial fibrillation is a predictor of in-hospital mortality in ischemic stroke patients
Ong CT, Wong YS, Wu CS, Su YH
Therapeutics and Clinical Risk Management 2016, 12:1057-1064
Published Date: 29 June 2016
The Oxfordshire Community Stroke Project classification system predicts clinical outcomes following intravenous thrombolysis: a prospective cohort study
Yang Y, Wang A, Zhao X, Wang C, Liu L, Zheng H, Wang Y, Cao Y, Wang Y
Therapeutics and Clinical Risk Management 2016, 12:1049-1056
Published Date: 29 June 2016
True anteroposterior view pedicle screw insertion technique
Bai JY, Zhang W, An JL, Sun YP, Ding WY, Shen Y
Therapeutics and Clinical Risk Management 2016, 12:1039-1047
Published Date: 29 June 2016
Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A
Castaman G, Linari S
Therapeutics and Clinical Risk Management 2016, 12:1029-1037
Published Date: 30 June 2016
Syncope as a presentation of acute pulmonary embolism
Altınsoy B, Erboy F, Tanrıverdi H, Uygur F, Örnek T, Atalay F, Tor M
Therapeutics and Clinical Risk Management 2016, 12:1023-1028
Published Date: 27 June 2016
Effects of no-reflow phenomenon on ventricular systolic synchrony in patients with acute anterior myocardial infarction after percutaneous coronary intervention
Wang L, Liu G, Liu J, Zheng M, Li L
Therapeutics and Clinical Risk Management 2016, 12:1017-1022
Published Date: 24 June 2016
New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim
Ghidini M, Hahne JC, Trevisani F, Panni S, Ratti M, Toppo L, Tomasello G
Therapeutics and Clinical Risk Management 2016, 12:1009-1015
Published Date: 24 June 2016
Direct thrombolysis of multiple thrombi in both right and left heart atrium in a patient on extracorporeal membrane oxygenation support following urgent double-lung transplantation: a case report
Pollert L, Prikrylova Z, Berousek J, Mosna F, Lischke R
Therapeutics and Clinical Risk Management 2016, 12:1003-1008
Published Date: 16 June 2016
Value of cyst localization to predict cystobiliary communication in patients undergoing conservative surgery with hydatid cyst
Alan B, Kapan M, Teke M, Hattapoğlu S, Arıkanoğlu Z
Therapeutics and Clinical Risk Management 2016, 12:995-1001
Published Date: 15 June 2016
Occupational HIV risk for health care workers: risk factor and the risk of infection in the course of professional activities
Wyżgowski P, Rosiek A, Grzela T, Leksowski K
Therapeutics and Clinical Risk Management 2016, 12:989-994
Published Date: 14 June 2016
Prescription of antibiotics in community-acquired pneumonia in children: are we following the recommendations?
Fonseca Lima EJ, Lima DEP, Serra GHC, Abreu e Lima MAZS, Mello MJG
Therapeutics and Clinical Risk Management 2016, 12:983-988
Published Date: 14 June 2016
Mesalazine-induced eosinophilic pneumonia with bone marrow infiltration: a case report and literature review
Zhang Y, Luo L, Wang X, Liu X, Wang X, Ding Y
Therapeutics and Clinical Risk Management 2016, 12:975-981
Published Date: 14 June 2016
A benefit–risk assessment model for statins using multicriteria decision analysis based on a discrete choice experiment in Korean patients
Byun JH, Kwon SH, Ha JH, Lee EK
Therapeutics and Clinical Risk Management 2016, 12:965-974
Published Date: 13 June 2016
Treatment of patients with chronic thromboembolic pulmonary hypertension: focus on riociguat
Smith ZR, Makowski CT, Awdish RL
Therapeutics and Clinical Risk Management 2016, 12:957-964
Published Date: 10 June 2016
Pazopanib in the management of advanced soft tissue sarcomas
Cranmer LD, Loggers ET, Pollack SM
Therapeutics and Clinical Risk Management 2016, 12:941-955
Published Date: 9 June 2016
Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI)
Leuthner KD, Buechler KA, Kogan D, Saguros A, Lee HS
Therapeutics and Clinical Risk Management 2016, 12:931-940
Published Date: 7 June 2016
A case of gait disturbance caused by low-dose gabapentin
Kanao-Kanda M, Kanda H, Takahata O, Kunisawa T
Therapeutics and Clinical Risk Management 2016, 12:927-929
Published Date: 9 June 2016
Management of chemotherapy-induced nausea and vomiting by risk profile: role of netupitant/palonosetron
Lorusso V
Therapeutics and Clinical Risk Management 2016, 12:917-925
Published Date: 7 June 2016
Clinical usefulness of mepolizumab in severe eosinophilic asthma
Menzella F, Lusuardi M, Montanari G, Galeone C, Facciolongo N, Zucchi L
Therapeutics and Clinical Risk Management 2016, 12:907-916
Published Date: 8 June 2016
Review of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studies
Bonsu KO, Owusu IK, Buabeng KO, Reidpath DD, Kadirvelu A
Therapeutics and Clinical Risk Management 2016, 12:887-906
Published Date: 3 June 2016
Herpetic esophagitis following bendamustine-containing regimen
Yamane H, Monobe Y, Tanikawa T, Ochi N, Honda Y, Kawamoto H, Takigawa N
Therapeutics and Clinical Risk Management 2016, 12:883-886
Published Date: 2 June 2016
Growth hormone therapy for Prader–Willi syndrome: challenges and solutions
Grugni G, Sartorio A, Crinò A
Therapeutics and Clinical Risk Management 2016, 12:873-881
Published Date: 2 June 2016
Combination ledipasvir-sofosbuvir for the treatment of chronic hepatitis C virus infection: a review and clinical perspective
Nkuize M, Sersté T, Buset M, Mulkay JP
Therapeutics and Clinical Risk Management 2016, 12:861-872
Published Date: 3 June 2016
The role of inflammation in cardiovascular diseases: the predictive value of neutrophil–lymphocyte ratio as a marker in peripheral arterial disease
Paquissi FC
Therapeutics and Clinical Risk Management 2016, 12:851-860
Published Date: 27 May 2016
How does the efficacy and safety of Oralair® compare to other products on the market?
Larenas-Linnemann D
Therapeutics and Clinical Risk Management 2016, 12:831-850
Published Date: 27 May 2016
Acute unstable complex radial head and neck fractures fixed with a mini T-shaped plate in a 20-year-old man: a case report
Yu W, Hu J, Zhang X, Zhu X, Xu Y, Yi J, Liu Y
Therapeutics and Clinical Risk Management 2016, 12:825-830
Published Date: 26 May 2016
Neuroprotection by triptolide against cerebral ischemia/reperfusion injury through the inhibition of NF-ΚB/PUMA signal in rats
Zhang B, Song C, Feng B, Fan W
Therapeutics and Clinical Risk Management 2016, 12:817-824
Published Date: 24 May 2016
Spotlight on afatinib and its potential in the treatment of squamous cell lung cancer: the evidence so far
Xu Y, Ding VW, Zhang H, Zhang X, Jablons D, He B
Therapeutics and Clinical Risk Management 2016, 12:807-816
Published Date: 24 May 2016
The potential utilizations of hydrogen as a promising therapeutic strategy against ocular diseases
Tao Y, Geng L, Xu WW, Qin LM, Peng GH, Huang YF
Therapeutics and Clinical Risk Management 2016, 12:799-806
Published Date: 19 May 2016
Critical evaluation of ceftolozane–tazobactam for complicated urinary tract and intra-abdominal infections
Giancola SE, Mahoney MV, Bias TE, Hirsch EB
Therapeutics and Clinical Risk Management 2016, 12:787-797
Published Date: 19 May 2016
Pathophysiology of hypophosphatasia and the potential role of asfotase alfa
Orimo H
Therapeutics and Clinical Risk Management 2016, 12:777-786
Published Date: 17 May 2016
Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
Sobolewska-Włodarczyk A, Włodarczyk M, Storr M, Fichna J
Therapeutics and Clinical Risk Management 2016, 12:771-775
Published Date: 13 May 2016
Association of glutathione S-transferase T1, M1, and P1 polymorphisms in the breast cancer risk: a meta-analysis
Song ZW, Shao C, Feng C, Lu YL, Gao Y, Dong CY
Therapeutics and Clinical Risk Management 2016, 12:763-769
Published Date: 12 May 2016
The effect of interferon gamma on conventional fractionated radiation-induced damage and fibrosis in the pelvic tissue of rabbits
Yang Y, Liu Z, Wang J, Chai Y, Su J, Shi F, Wang J, Che SM
Therapeutics and Clinical Risk Management 2016, 12:755-762
Published Date: 11 May 2016
Recovery of a 10-year-old girl from methicillin-resistant Staphylococcus aureus sepsis in response to low-dose ceftaroline treatment
Borgmann S, Rieß B, Wernitz-Keibel T, Bühler M, Layer F, Strommenger B
Therapeutics and Clinical Risk Management 2016, 12:749-753
Published Date: 11 May 2016
Microplasma radiofrequency technology combined with triamcinolone improved the therapeutic effect on Chinese patients with hypertrophic scar and reduced the risk of tissue atrophy
Yu S, Li H
Therapeutics and Clinical Risk Management 2016, 12:743-747
Published Date: 10 May 2016
New treatment options for ALK+ advanced non-small-cell lung cancer: critical appraisal of ceritinib
Rothschild SI
Therapeutics and Clinical Risk Management 2016, 12:735-741
Published Date: 5 May 2016
Emerging drugs for partial-onset epilepsy: a review of brivaracetam
Gao L, Li SC
Therapeutics and Clinical Risk Management 2016, 12:719-734
Published Date: 4 May 2016
Effect of ketamine combined with butorphanol on emergence agitation of postoperative patients with gastric cancer
Lin L, Liu SC, Chen ZY, Lin SL
Therapeutics and Clinical Risk Management 2016, 12:713-717
Published Date: 4 May 2016
Diagnosis and screening of patients with hereditary angioedema in primary care
Henao MP, Kraschnewski JL, Kelbel T, Craig TJ
Therapeutics and Clinical Risk Management 2016, 12:701-711
Published Date: 2 May 2016
Management of acute and delayed chemotherapy-induced nausea and vomiting: role of netupitant–palonosetron combination
Janicki PK
Therapeutics and Clinical Risk Management 2016, 12:693-699
Published Date: 2 May 2016
High-intensity focused ultrasound therapy in combination with gemcitabine for unresectable pancreatic carcinoma
Lv W, Yan T, Wang G, Zhao W, Zhang T, Zhou D
Therapeutics and Clinical Risk Management 2016, 12:687-691
Published Date: 2 May 2016
Comparison of anterior decompression and fusion versus laminoplasty in the treatment of multilevel cervical ossification of the posterior longitudinal ligament: a systematic review and meta-analysis
Liu W, Hu L, Chou PH, Liu M, Kan W, Wang J
Therapeutics and Clinical Risk Management 2016, 12:675-685
Published Date: 26 April 2016
Comparative risk impact of edoxaban in the management of stroke and venous thromboembolism
Tellor KB, Van Tuyl JS, Armbruster AL
Therapeutics and Clinical Risk Management 2016, 12:667-674
Published Date: 26 April 2016
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: are they useful for predicting gestational diabetes mellitus during pregnancy?
Sargın MA, Yassa M, Taymur BD, Celik A, Ergun E, Tug N
Therapeutics and Clinical Risk Management 2016, 12:657-665
Published Date: 26 April 2016
Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio reliable parameters as prognostic indicators in malignant mesothelioma?
Tural Onur S, Sokucu SN, Dalar L, Iliaz S, Kara K, Buyukkale S, Altin S
Therapeutics and Clinical Risk Management 2016, 12:651-656
Published Date: 22 April 2016
Absorbable scaphoid screw development: a comparative study on biomechanics
Wang Y, Song MG, Xu YQ, He XQ, Zhu YL
Therapeutics and Clinical Risk Management 2016, 12:643-650
Published Date: 22 April 2016
The Psoriatic Arthritis Impact of Disease 12-item questionnaire: equivalence, reliability, validity, and feasibility of the touch-screen administration versus the paper-and-pencil version
Salaffi F, Di Carlo M, Carotti M, Farah S, Gutierrez M
Therapeutics and Clinical Risk Management 2016, 12:631-642
Published Date: 21 April 2016
Cardiac, renal, and neurological benefits of preoperative levosimendan administration in patients with right ventricular dysfunction and pulmonary hypertension undergoing cardiac surgery: evaluation with two biomarkers neutrophil gelatinase-associated lipocalin and neuronal enolase
Guerrero-Orriach JL, Ariza-Villanueva D, Florez-Vela A, Garrido-Sánchez L, Moreno-Cortés MI, Galán-Ortega M, Ramírez-Fernández A, Alcaide Torres J, Santiago Fernandez C, Navarro Arce I, Melero-Tejedor JM, Rubio-Navarro M, Cruz-Mañas J
Therapeutics and Clinical Risk Management 2016, 12:623-630
Published Date: 21 April 2016
Are the blood groups of women with preeclampsia a risk factor for the development of hypertension postpartum?
Avci D, Karagoz H, Ozer O, Esmeray K, Bulut K, Aykas F, Cetinkaya A, Uslu E, Karahan S, Basak M, Erden A
Therapeutics and Clinical Risk Management 2016, 12:617-622
Published Date: 19 April 2016
Effects of first-dose volume and exercise on the efficacy and tolerability of bowel preparations for colonoscopy in Chinese people
Qin Y, Liu W, Lin S, Li X
Therapeutics and Clinical Risk Management 2016, 12:613-616
Published Date: 15 April 2016
The application of nutrition support in conservative treatment of chylous ascites after abdominal surgery
Pan W, Cai SY, Luo HL, Ouyang SR, Zhang WD, Wei ZR, Wang DL
Therapeutics and Clinical Risk Management 2016, 12:607-612
Published Date: 15 April 2016
The influence of methods of bariatric surgery for treatment of type 2 diabetes mellitus
Bužga M, Maresova P, Seidlerová A, Zonča P, Holéczy P, Kuča K
Therapeutics and Clinical Risk Management 2016, 12:599-605
Published Date: 15 April 2016
Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine
Wang XY, Lim-Jurado M, Prepageran N, Tantilipikorn P, Wang DY
Therapeutics and Clinical Risk Management 2016, 12:585-597
Published Date: 13 April 2016
Application of surgical navigation in styloidectomy for treating Eagle’s syndrome
Dou G, Zhang Y, Zong CL, Chen YL, Guo YX, Tian L
Therapeutics and Clinical Risk Management 2016, 12:575-583
Published Date: 12 April 2016
Patient considerations and drug selection in the treatment of idiopathic pulmonary fibrosis
Trawinska MA, Rupesinghe RD, Hart SP
Therapeutics and Clinical Risk Management 2016, 12:563-574
Published Date: 8 April 2016
Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene
Kagan R, Goldstein SR, Pickar JH, Komm BS
Therapeutics and Clinical Risk Management 2016, 12:549-562
Published Date: 7 April 2016
Dysplasia epiphysealis hemimelica (Trevor disease) in the ankle
Ozan F, Doğar F, Gürbüz K, Ekinci Y, Bilal Ö, Öncel ES
Therapeutics and Clinical Risk Management 2016, 12:545-547
Published Date: 6 April 2016
Safe medication management and use of narcotics in a Joint Commission International-accredited academic medical center hospital in the People’s Republic of China
Fang X, Zhu LL, Pan SD, Xia P, Chen M, Zhou Q
Therapeutics and Clinical Risk Management 2016, 12:535-544
Published Date: 6 April 2016
Clinical effects and safety of treating diabetic macular edema with intravitreal injection of ranibizumab combined with retinal photocoagulation
Yan PS, Qian C, Wang WZ, Dong Y, Wan GM, Chen Y
Therapeutics and Clinical Risk Management 2016, 12:527-533
Published Date: 5 April 2016
Management of children’s acute diarrhea by community pharmacies in five towns of Ethiopia: simulated client case study
Abegaz TM, Belachew SA, Abebe TB, Gebresilassie BM, Teni FS, Woldie HG
Therapeutics and Clinical Risk Management 2016, 12:515-526
Published Date: 5 April 2016
Dysfunction of the thyroid gland during amiodarone therapy: a study of 297 cases
Czarnywojtek A, Płazińska MT, Zgorzalewicz-Stachowiak M, Woliński K, Stangierski A, Miechowicz I, Waligórska-Stachura J, Gut P, Królicki L, Zioncheck M, Ruchała M
Therapeutics and Clinical Risk Management 2016, 12:505-513
Published Date: 4 April 2016
Impact of baseline characteristics on outcomes of carotid artery stenting in acute ischemic stroke patients
Yu CS, Lin CM, Liu CK, Lu HHS
Therapeutics and Clinical Risk Management 2016, 12:495-504
Published Date: 31 March 2016
Correlation of visceral adiposity index with chronic kidney disease in the People’s Republic of China: to rediscover the new clinical potential of an old indicator for visceral obesity
Xu XM, Zhao Y, Zhao ZH, Zhu SS, Liu XY, Zhou CM, Shao XF, Liang Y, Duan CY, Holthöfer H, Zou HQ
Therapeutics and Clinical Risk Management 2016, 12:489-494
Published Date: 29 March 2016
Guidelines for acute management of hyperammonemia in the Middle East region
Alfadhel M, Al Mutairi F, Makhseed N, Al Jasmi F, Al-Thihli K, Al-Jishi E, AlSayed M, Al-Hassnan ZN, Al-Murshedi F, Häberle J, Ben-Omran T
Therapeutics and Clinical Risk Management 2016, 12:479-487
Published Date: 31 March 2016
Combination therapies in the management of type 2 diabetes: the use of insulin degludec/liraglutide
Minze MG, Chastain LM
Therapeutics and Clinical Risk Management 2016, 12:471-478
Published Date: 29 March 2016
The impact of oxidized serum albumin on the oncotic pressure and hydration status of peritoneal dialysis patients
Hassan K, Kristal B, Hassan F, Abo Saleh S, Michelis R
Therapeutics and Clinical Risk Management 2016, 12:463-469
Published Date: 24 March 2016
Post-stroke bacteriuria among stroke patients attending a physiotherapy clinic in Ghana: a cross-sectional study
Donkor ES, Akumwena A, Amoo PK, Owolabi MO, Aspelund T, Gudnason V
Therapeutics and Clinical Risk Management 2016, 12:457-462
Published Date: 17 March 2016
Development and novel therapeutics in hepatocellular carcinoma: a review
Ingle PV, Samsudin SZ, Chan PQ, Ng MK, Heng LX, Yap SC, Chai ASH, Wong ASY
Therapeutics and Clinical Risk Management 2016, 12:445-455
Published Date: 16 March 2016
The effect of sitagliptin on cardiovascular risk profile in Korean patients with type 2 diabetes mellitus: a retrospective cohort study
Shin S, Kim H
Therapeutics and Clinical Risk Management 2016, 12:435-444
Published Date: 15 March 2016
Prevalence of diabetes and determinants: evidence from a minority region in People’s Republic of China
Chen Q, Yi Y, Xia N, Li C, Luo Z, Huang G, Chen Y, Li S, Lai L, Wang M, Tan J, Zhang J, Shen H, Li B, Su F, Wei H, Dai X, Lu F, Li S
Therapeutics and Clinical Risk Management 2016, 12:427-433
Published Date: 14 March 2016
Antibiotic prescribing and resistance: knowledge level of medical students of clinical years of University Sultan Zainal Abidin, Malaysia
Haque M, Rahman NIA, Zulkifli Z, Ismail S
Therapeutics and Clinical Risk Management 2016, 12:413-426
Published Date: 11 March 2016
Methylnaltrexone for opioid-induced constipation: review and meta-analyses for objective plus subjective efficacy and safety outcomes
Siemens W, Becker G
Therapeutics and Clinical Risk Management 2016, 12:401-412
Published Date: 11 March 2016
Concentrated insulins: the new basal insulins
Lamos EM, Younk LM, Davis SN
Therapeutics and Clinical Risk Management 2016, 12:389-400
Published Date: 9 March 2016
Cone-beam computed tomography study of the root and canal morphology of mandibular permanent anterior teeth in a Chongqing population [Corrigendum]
Yang ZY, Lu KK, Wang F, Li YH, Zhou Z
Therapeutics and Clinical Risk Management 2016, 12:387-388
Published Date: 10 March 2016
Effect of Ascaris lumbricoides infection on T helper cell type 2 in rural Egyptian children
Shalaby NM, Shalaby NM
Therapeutics and Clinical Risk Management 2016, 12:379-385
Published Date: 9 March 2016
Comparison of propofol–hydromorphone and propofol–dexmedetomidine in patients with intubation after maxillofacial plastic surgery
Peng W, Zhang T, Wang Y
Therapeutics and Clinical Risk Management 2016, 12:373-377
Published Date: 8 March 2016
Allergic diseases among children: nutritional prevention and intervention
Hendaus MA, Jomha FA, Ehlayel M
Therapeutics and Clinical Risk Management 2016, 12:361-372
Published Date: 7 March 2016
Reduction in total recurrent cardiovascular events in acute coronary syndrome patients with low-density lipoprotein cholesterol goal <70 mg/dL: a real-life cohort in a developing country
Chinwong S, Patumanond J, Chinwong D, Hall JJ, Phrommintikul A
Therapeutics and Clinical Risk Management 2016, 12:353-360
Published Date: 3 March 2016
The use of oral suspension and rationally prescribing alternatives may be supplemental to the implementation of clopidogrel new algorithm comprising CYP2C19 pharmacogenetics and drug interactions
Chen M, Zhou Q
Therapeutics and Clinical Risk Management 2016, 12:351-352
Published Date: 2 March 2016
Dimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerations
Prosperini L, Pontecorvo S
Therapeutics and Clinical Risk Management 2016, 12:339-350
Published Date: 2 March 2016
TotalTrack video intubating laryngeal mask in super-obese patients – series of cases
Gaszynski T
Therapeutics and Clinical Risk Management 2016, 12:335-338
Published Date: 2 March 2016
Evaluation of safety and efficacy of zonisamide in adult patients with partial, generalized, and combined seizures: an open labeled, noncomparative, observational Indian study
Dash A, Ravat S, Srinivasan AV, Shetty A, Kumar V, Achtani R, Mathur VN, Maramattom BV, Bajpai V, Manjunath NC, Narayana RV, Mehta S
Therapeutics and Clinical Risk Management 2016, 12:327-334
Published Date: 29 February 2016
Clinical utility of nivolumab in the treatment of advanced melanoma
Asmar R, Yang J, Carvajal RD
Therapeutics and Clinical Risk Management 2016, 12:313-325
Published Date: 26 February 2016
Male sex, height, weight, and body mass index can increase external pressure to calf region using knee-crutch-type leg holder system in lithotomy position
Mizuno J, Takahashi T
Therapeutics and Clinical Risk Management 2016, 12:305-312
Published Date: 25 February 2016
Radiofrequency ablation versus resection for Barcelona clinic liver cancer very early/early stage hepatocellular carcinoma: a systematic review
He ZX, Xiang P, Gong JP, Cheng NS, Zhang W
Therapeutics and Clinical Risk Management 2016, 12:295-303
Published Date: 23 February 2016
Ethyl pyruvate protects against sepsis by regulating energy metabolism
Kang H, Mao Z, Zhao Y, Yin T, Song Q, Pan L, Hu X, Hu J, Zhou F
Therapeutics and Clinical Risk Management 2016, 12:287-294
Published Date: 23 February 2016
Effect of red yeast rice combined with antioxidants on lipid pattern, hs-CRP level, and endothelial function in moderately hypercholesterolemic subjects
Cicero AF, Morbini M, Parini A, Urso R, Rosticci M, Grandi E, Borghi C
Therapeutics and Clinical Risk Management 2016, 12:281-286
Published Date: 23 February 2016
Is ketamine a lifesaving agent in childhood acute severe asthma?
Hendaus MA, Jomha FA, Alhammadi AH
Therapeutics and Clinical Risk Management 2016, 12:273-279
Published Date: 22 February 2016
Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations
Ayzenberg I, Hoepner R, Kleiter I
Therapeutics and Clinical Risk Management 2016, 12:261-272
Published Date: 19 February 2016
Bacterial profile of urinary tract infection and antimicrobial susceptibility pattern among pregnant women attending at Antenatal Clinic in Dil Chora Referral Hospital, Dire Dawa, Eastern Ethiopia
Derese B, Kedir H, Teklemariam Z, Weldegebreal F, Balakrishnan S
Therapeutics and Clinical Risk Management 2016, 12:251-260
Published Date: 18 February 2016
Effectiveness of the clinical pharmacist in reducing mortality in hospitalized cardiac patients: a propensity score-matched analysis
Zhai XB, Gu ZC, Liu XY
Therapeutics and Clinical Risk Management 2016, 12:241-250
Published Date: 18 February 2016
Drug-related problems in a sample of outpatients with chronic diseases: a cross-sectional study from Jordan
Al-Azzam SI, Alzoubi KH, AbuRuz S, Alefan Q
Therapeutics and Clinical Risk Management 2016, 12:233-239
Published Date: 17 February 2016
New developments in the treatment of acute bacterial skin and skin structure infections: considerations for the effective use of dalbavancin
Juul JJ, Mullins CF, Peppard WJ, Huang AM
Therapeutics and Clinical Risk Management 2016, 12:225-232
Published Date: 16 February 2016
Influence of MDR1 methylation on the curative effect of interventional embolism chemotherapy for cervical cancer
Huang Z, Zhang S, Shen YP, Liu WX, Long JP, Zhou S
Therapeutics and Clinical Risk Management 2016, 12:217-223
Published Date: 15 February 2016
New combinations in the treatment of COPD: rationale for aclidinium–formoterol
Incorvaia C, Montagni M, Makri E, Ridolo E
Therapeutics and Clinical Risk Management 2016, 12:209-215
Published Date: 15 February 2016
Evaluation of a new tablet formulation of deferasirox to reduce chronic iron overload after long-term blood transfusions
Chalmers AW, Shammo JM
Therapeutics and Clinical Risk Management 2016, 12:201-208
Published Date: 15 February 2016
IgG4-related disease: current challenges and future prospects
Lang D, Zwerina J, Pieringer H
Therapeutics and Clinical Risk Management 2016, 12:189-199
Published Date: 15 February 2016
Low-back pain at the emergency department: still not being managed?
Rizzardo A, Miceli L, Bednarova R, Guadagnin GM, Sbrojavacca R, Della Rocca G
Therapeutics and Clinical Risk Management 2016, 12:183-187
Published Date: 12 February 2016
Intravitreal ketorolac for the treatment of chronic cystoid macular edema after cataract surgery
Tsilimbaris MK, Tsika C, Kymionis GD
Therapeutics and Clinical Risk Management 2016, 12:177-182
Published Date: 12 February 2016
Optimal medical therapy for secondary prevention after an acute coronary syndrome: 18-month follow-up results at a tertiary teaching hospital in South Korea
Byeon HJ, Yang YM, Choi EJ
Therapeutics and Clinical Risk Management 2016, 12:167-175
Published Date: 12 February 2016
Intermittent negative pressure wound therapy with instillation for the treatment of persistent periprosthetic hip infections: a report of two cases
Söylemez MS, Özkan K, Kılıç B, Erinç S
Therapeutics and Clinical Risk Management 2016, 12:161-166
Published Date: 10 February 2016
A retrospective drug use evaluation of cabergoline for lactation inhibition at a tertiary care teaching hospital in Qatar
AlSaad D, ElSalem S, Abdulrouf PV, Thomas B, Alsaad T, Ahmad A, AlHail M
Therapeutics and Clinical Risk Management 2016, 12:155-160
Published Date: 9 February 2016
Considerations on patient-related outcomes with the use of botulinum toxins: is switching products safe?
Fraint A, Vittal P, Comella C
Therapeutics and Clinical Risk Management 2016, 12:147-154
Published Date: 5 February 2016
Effect of a nonsurgical treatment program on the gait pattern of idiopathic toe walking: a case report
Szopa A, Domagalska˗Szopa M, Gallert˗Kopyto W, Kiebzak W, Plinta R
Therapeutics and Clinical Risk Management 2016, 12:139-146
Published Date: 10 February 2016
Sudoscan as a noninvasive tool to assess sudomotor dysfunction in patients with Fabry disease: results from a case–control study
Sahuc P, Chiche L, Dussol B, Pouget J, Franques J
Therapeutics and Clinical Risk Management 2016, 12:135-138
Published Date: 2 February 2016
Nutritional management in an elderly man with esophageal and gastric necrosis after caustic soda ingestion: a case report
Rondanelli M, Peroni G, Miccono A, Guerriero F, Guido D, Perna S
Therapeutics and Clinical Risk Management 2016, 12:129-133
Published Date: 4 February 2016
Association of nuclear and mitochondrial genes with audiological examinations in Iranian patients with nonaminoglycoside antibiotics-induced hearing loss
Balali M, Kamalidehghan B, Farhadi M, Ahmadipour F, Ashkezari MD, Hemami MR, Arabzadeh H, Falah M, Meng GY, Houshmand M
Therapeutics and Clinical Risk Management 2016, 12:117-128
Published Date: 28 January 2016
A critical appraisal of paliperidone long-acting injection in the treatment of schizoaffective disorder
Chue P, Chue J
Therapeutics and Clinical Risk Management 2016, 12:109-116
Published Date: 27 January 2016
A new modified technique of laparoscopic needle catheter jejunostomy: a 2-year follow-up study
Ye P, Zeng LP, Sun FH, An Z, Li ZB, Hu J
Therapeutics and Clinical Risk Management 2016, 12:103-108
Published Date: 25 January 2016
Risk factors associated with postoperative pain after ophthalmic surgery: a prospective study
Lesin M, Dzaja Lozo M, Duplancic-Sundov Z, Dzaja I, Davidovic N, Banozic A, Puljak L
Therapeutics and Clinical Risk Management 2016, 12:93-102
Published Date: 22 January 2016
Reduction of group A beta-hemolytic streptococcus pharyngo-tonsillar infections associated with use of the oral probiotic Streptococcus salivarius K12: a retrospective observational study
Gregori G, Righi O, Risso P, Boiardi G, Demuru G, Ferzetti A, Galli A, Ghisoni M, Lenzini S, Marenghi C, Mura C, Sacchetti R, Suzzani L
Therapeutics and Clinical Risk Management 2016, 12:87-92
Published Date: 19 January 2016
Effects of propofol versus sevoflurane on cerebral oxygenation and cognitive outcome in patients with impaired cerebral oxygenation
Guo JY, Fang JY, Xu SR, Wei M, Huang WQ
Therapeutics and Clinical Risk Management 2016, 12:81-85
Published Date: 18 January 2016
The value of trabectedin in the treatment of soft tissue sarcoma
Nakamura T, Matsumine A, Sudo A
Therapeutics and Clinical Risk Management 2016, 12:73-79
Published Date: 13 January 2016
Comparison of three approaches of Bernese periacetabular osteotomy
Luo DZ, Zhang H, Zhang WJ
Therapeutics and Clinical Risk Management 2016, 12:67-72
Published Date: 12 January 2016
Video-assisted thoracic surgery reduces early postoperative stress. A single-institutional prospective randomized study
Asteriou C, Lazopoulos A, Rallis T, Gogakos AS, Paliouras D, Tsakiridis K, Zissimopoulos A, Tsavlis D, Porpodis K, Hohenforst-Schmidt W, Kioumis I, Organtzis J, Zarogoulidis K, Zarogoulidis P, Barbetakis N
Therapeutics and Clinical Risk Management 2016, 12:59-65
Published Date: 12 January 2016
Profile of eliglustat tartrate in the management of Gaucher disease
Sechi A, Dardis A, Bembi B
Therapeutics and Clinical Risk Management 2016, 12:53-58
Published Date: 11 January 2016
Treatment of Rockwood type III acromioclavicular joint dislocation using autogenous semitendinosus tendon graft and endobutton technique
Ye G, Peng CA, Sun HB, Xiao J, Zhu K
Therapeutics and Clinical Risk Management 2016, 12:47-51
Published Date: 11 January 2016
Particulate matter is associated with sputum culture conversion in patients with culture-positive tuberculosis
Chen KY, Chuang KJ, Liu HC, Lee KY, Feng PH, Su CL, Lin CL, Lee CN, Chuang HC
Therapeutics and Clinical Risk Management 2016, 12:41-46
Published Date: 6 January 2016
A critical appraisal of atomoxetine in the management of ADHD
Childress AC
Therapeutics and Clinical Risk Management 2016, 12:27-39
Published Date: 23 December 2015
Cone-beam computed tomography study of the root and canal morphology of mandibular permanent anterior teeth in a Chongqing population
Zhengyan Y, Keke L, Fei W, Yueheng L, Zhi Z
Therapeutics and Clinical Risk Management 2016, 12:19-25
Published Date: 23 December 2015
Abnormal expression levels of sMICA and NKG2D are correlated with poor prognosis in pancreatic cancer
Chen J, Xu H, Zhu XX
Therapeutics and Clinical Risk Management 2016, 12:11-18
Published Date: 22 December 2015
The role of additional computed tomography in the decision-making process on the secondary prevention in patients after systemic cerebral thrombolysis
Sobolewski P, Kozera G, Szczuchniak W, Nyka WM
Therapeutics and Clinical Risk Management 2016, 12:5-10
Published Date: 23 December 2015
Coexistence of squamous cell tracheal papilloma and carcinoma treated with chemotherapy and radiotherapy: a case report
Paliouras D, Gogakos A, Rallis T, Chatzinikolaou F, Asteriou C, Tagarakis G, Organtzis J, Tsakiridis K, Tsavlis D, Zissimopoulos A, Kioumis I, Hohenforst-Schmidt W, Zarogoulidis K, Zarogoulidis P, Barbetakis N
Therapeutics and Clinical Risk Management 2016, 12:1-4
Published Date: 21 December 2015